{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:04:08Z","timestamp":1790849048938,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cataract surgery is one of the most commonly performed surgeries worldwide, and is traditionally followed by a postoperative regimen of eyedrops to reduce the risk of infection and inflammation. However, variable adherence to treatment and the burden of administering drops pose significant challenges. \u201cDropless after cataract surgery\u201d (DACS) has emerged as an approach where intraoperative delivery may eliminate the need for postoperative drops. DACS offers a simplified alternative to eyedrop therapy, with the potential to improve patient-related quality of life, lower healthcare costs, and promote sustainable practices by reducing medical waste. Multiple studies over the past few decades have demonstrated the effectiveness of intraoperative intracameral antibiotics alone in reducing endophthalmitis rates, thus eliminating the need for topical antibiotic drops. Sustained-release steroid formulations have demonstrated reliable control of postoperative inflammation, similar to those achieved with standard topical regimens, but their adoption remains limited. Realising the full benefits of DACS will require systemic barriers to be addressed, and dropless regimens should be considered within a holistic value-based healthcare approach. As the global burden of cataract surgery continues to grow, embracing dropless techniques may represent a forward-looking step in modernising postoperative management to optimise patient-centred care.<\/jats:p>","DOI":"10.1038\/s41433-026-04604-z","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:50:25Z","timestamp":1782453025000},"page":"1602-1617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dropless after cataract surgery (DACS): concepts, evidence and clinical potential"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7699-2112","authenticated-orcid":false,"given":"Johannes","family":"Birtel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9300-573X","authenticated-orcid":false,"given":"Ariel Yuhan","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolin","family":"Deichl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Mole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sher A.","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0351-6673","authenticated-orcid":false,"given":"Peter","family":"Charbel Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"4604_CR1","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jcrs.2007.02.032","volume":"33","author":"ESCRS Endophthalmitis Study Group","year":"2007","unstructured":"ESCRS Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors. J Cataract Refractive Surg. 2007;33:978\u201388. https:\/\/doi.org\/10.1016\/j.jcrs.2007.02.032.","journal-title":"J Cataract Refractive Surg"},{"key":"4604_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006364","volume":"2","author":"EW Gower","year":"2017","unstructured":"Gower EW, Lindsley K, Tulenko SE, Nanji AA, Leyngold I, McDonnell PJ. Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. Cochrane Database Syst Rev. 2017;2:CD006364. https:\/\/doi.org\/10.1002\/14651858.CD006364.","journal-title":"Cochrane Database Syst Rev"},{"key":"4604_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/j.jcrs.0000000000000757","volume":"48","author":"DF Chang","year":"2022","unstructured":"Chang DF, Rhee DJ. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2021 ASCRS member survey. J Cataract Refract Surg. 2022;48:3\u20137. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000000757.","journal-title":"J Cataract Refract Surg"},{"key":"4604_CR4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jcrs.2009.01.004","volume":"35","author":"DM Gore","year":"2009","unstructured":"Gore DM, Angunawela RI, Little BC. United Kingdom survey of antibiotic prophylaxis practice after publication of the ESCRS Endophthalmitis Study. J Cataract Refract Surg. 2009;35:770\u20133. https:\/\/doi.org\/10.1016\/j.jcrs.2009.01.004.","journal-title":"J Cataract Refract Surg"},{"key":"4604_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/aos.17469","volume":"103","author":"ML Passaro","year":"2025","unstructured":"Passaro ML, Posarelli M, Avolio FC, Ferrara M, Costagliola C, Semeraro F, et al. Evaluating the efficacy of postoperative topical antibiotics in cataract surgery: A systematic review and meta-analysis. Acta Ophthalmol. 2025;103:622\u201333. https:\/\/doi.org\/10.1111\/aos.17469.","journal-title":"Acta Ophthalmol"},{"key":"4604_CR6","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1111\/aos.15732","volume":"102","author":"M Ferrara","year":"2024","unstructured":"Ferrara M, Gatti F, Lockington D, Iaria A, Kaye S, Virgili G, et al. Antimicrobials and antiseptics: Lowering effect on ocular surface bacterial flora\u2014A systematic review. Acta Ophthalmol. 2024;102:e215\u2013e228. https:\/\/doi.org\/10.1111\/aos.15732.","journal-title":"Acta Ophthalmol"},{"key":"4604_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ajo.2024.01.007","volume":"261","author":"V Romano","year":"2024","unstructured":"Romano V, Ferrara M, Gatti F, Airaldi M, Borroni D, Aragona E, et al. Topical antiseptics in minimizing ocular surface bacterial load before ophthalmic surgery: a randomized controlled trial. Am J Ophthalmol. 2024;261:165\u201375. https:\/\/doi.org\/10.1016\/j.ajo.2024.01.007.","journal-title":"Am J Ophthalmol"},{"key":"4604_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1172345","volume":"13","author":"F Hotta","year":"2023","unstructured":"Hotta F, Eguchi H, Kuwahara T, Nakayama-Imaohji H, Shimomura Y, Kusaka S. Disturbances in the ocular surface microbiome by perioperative antimicrobial eye drops. Front Cell Infect Microbiol. 2023;13:1172345. https:\/\/doi.org\/10.3389\/fcimb.2023.1172345.","journal-title":"Front Cell Infect Microbiol"},{"key":"4604_CR9","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.ophtha.2015.08.024","volume":"122","author":"NH Shorstein","year":"2015","unstructured":"Shorstein NH, Liu L, Waxman MD, Herrinton LJ. Comparative effectiveness of three prophylactic strategies to prevent clinical macular edema after phacoemulsification surgery. Ophthalmology. 2015;122:2450\u20136. https:\/\/doi.org\/10.1016\/j.ophtha.2015.08.024.","journal-title":"Ophthalmology"},{"key":"4604_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/aos.14175","volume":"98","author":"JM Lindholm","year":"2020","unstructured":"Lindholm JM, Taipale C, Ylinen P, Tuuminen R. Perioperative subconjunctival triamcinolone acetonide injection for prevention of inflammation and macular oedema after cataract surgery. Acta Ophthalmol. 2020;98:36\u201342. https:\/\/doi.org\/10.1111\/aos.14175.","journal-title":"Acta Ophthalmol"},{"key":"4604_CR11","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.2147\/OPTH.S426200","volume":"17","author":"AM Wu","year":"2023","unstructured":"Wu AM, Pitts KM, Pineda R, Chen SH, Wang M, Johnson G, et al. Steroid response following dropless cataract surgery using subconjunctival triamcinolone. Clin Ophthalmol. 2023;17:2803\u201314. https:\/\/doi.org\/10.2147\/OPTH.S426200.","journal-title":"Clin Ophthalmol"},{"key":"4604_CR12","doi-asserted-by":"publisher","unstructured":"Shorstein NH, McCabe SE, Alavi M, Kwan ML, Chandra NS. Triamcinolone acetonide subconjunctival injection as stand-alone inflammation prophylaxis after phacoemulsification cataract surgery. Ophthalmology. 2024;0. https:\/\/doi.org\/10.1016\/j.ophtha.2024.03.025.","DOI":"10.1016\/j.ophtha.2024.03.025"},{"key":"4604_CR13","unstructured":"Norris T ESCRS EPICAT Study Updates [Internet]. [cited 2025 Apr 6]. Available from: https:\/\/www.escrs.org\/"},{"key":"4604_CR14","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.jcrs.2011.03.049","volume":"37","author":"M Dieleman","year":"2011","unstructured":"Dieleman M, Wubbels RJ, van Kooten-Noordzij M, de Waard PW. Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery. J Cataract Refract Surg. 2011;37:1589\u201397. https:\/\/doi.org\/10.1016\/j.jcrs.2011.03.049.","journal-title":"J Cataract Refract Surg"},{"key":"4604_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/aos.12358","volume":"92","author":"N Merkoudis","year":"2014","unstructured":"Merkoudis N, Wikberg Matsson A, Granstam E. Comparison of peroperative subconjunctival injection of methylprednisolone and standard postoperative steroid drops after uneventful cataract surgery. Acta Ophthalmol. 2014;92:623\u20138. https:\/\/doi.org\/10.1111\/aos.12358.","journal-title":"Acta Ophthalmol"},{"key":"4604_CR16","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1167\/iovs.08-2920","volume":"50","author":"F Paganelli","year":"2009","unstructured":"Paganelli F, Cardillo JA, Melo LA, Lucena DR, Silva AA, Oliveira AG, et al. A single intraoperative sub-tenon\u2019s capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery. Invest Ophthalmol Vis Sci. 2009;50:3041\u20137. https:\/\/doi.org\/10.1167\/iovs.08-2920.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4604_CR17","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jcrs.2005.12.102","volume":"32","author":"AK Negi","year":"2006","unstructured":"Negi AK, Browning AC, Vernon SA. Single perioperative triamcinolone injection versus standard postoperative steroid drops after uneventful phacoemulsification surgery: Randomized controlled trial. J Cataract Refract Surg. 2006;32:468\u201374. https:\/\/doi.org\/10.1016\/j.jcrs.2005.12.102.","journal-title":"J Cataract Refract Surg"},{"key":"4604_CR18","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/j.ophtha.2004.04.026","volume":"111","author":"F Paganelli","year":"2004","unstructured":"Paganelli F, Cardillo JA, Melo LA, Oliveira AG, Skaf M, Costa RA, et al. A single intraoperative sub-Tenon\u2019s capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation. Ophthalmology. 2004;111:2102\u20138. https:\/\/doi.org\/10.1016\/j.ophtha.2004.04.026.","journal-title":"Ophthalmology"},{"key":"4604_CR19","first-page":"1127","volume":"66","author":"H Khan","year":"2016","unstructured":"Khan H, Alam M, Khan A. Comparison of the safety and efficacy of single injection of subtenon triamcinolone and topical dexamethasone in reducing postoperative inflammation after phacoemulsification and intraocular lens implantation. J Pak Med Assoc. 2016;66:1127\u201331.","journal-title":"J Pak Med Assoc"},{"key":"4604_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20522-y","volume":"12","author":"P Choopong","year":"2022","unstructured":"Choopong P, Taetrongchit N, Boonsopon S, Nimkarn A, Srisukkosalin K, Chonpimai P, et al. Efficacy of subtenon 20-mg triamcinolone injection versus 0.1% dexamethasone eye drops for controlling inflammation after phacoemulsification: a randomized controlled trial. Sci Rep. 2022;12:16471. https:\/\/doi.org\/10.1038\/s41598-022-20522-y.","journal-title":"Sci Rep"},{"key":"4604_CR21","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1055\/s-0043-1771043","volume":"15","author":"EK Wotipka","year":"2023","unstructured":"Wotipka EK, Wright AJ, Fan JZ, Fuhriman D, Chuang AZ, Lindhorst GC, et al. Postoperative complications of true dropless cataract surgery versus standard topical drops. J Acad Ophthalmol (2017). 2023;15:e144\u2013e153. https:\/\/doi.org\/10.1055\/s-0043-1771043.","journal-title":"J Acad Ophthalmol (2017)"},{"key":"4604_CR22","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jamaophthalmol.2021.2976","volume":"139","author":"JH Erichsen","year":"2021","unstructured":"Erichsen JH, Holm LM, Forslund Jacobsen M, Forman JL, Kessel L. Prednisolone and ketorolac vs ketorolac monotherapy or sub-tenon prophylaxis for macular thickening in cataract surgery: a randomized clinical trial. JAMA Ophthalmol. 2021;139:1062\u201370. https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.2976.","journal-title":"JAMA Ophthalmol"},{"key":"4604_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1600-0420.2007.01114.x","volume":"86","author":"A Karalezli","year":"2008","unstructured":"Karalezli A, Borazan M, Akova YA. Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification. Acta Ophthalmol. 2008;86:183\u20137. https:\/\/doi.org\/10.1111\/j.1600-0420.2007.01114.x.","journal-title":"Acta Ophthalmol"},{"key":"4604_CR24","first-page":"819","volume":"94","author":"P Simaroj","year":"2011","unstructured":"Simaroj P, Sinsawad P, Lekhanont K. Effects of intracameral triamcinolone and gentamicin injections following cataract surgery. J Med Assoc Thai. 2011;94:819\u201325. Jul.","journal-title":"J Med Assoc Thai"},{"key":"4604_CR25","first-page":"19","volume":"34","author":"A Manzoor","year":"2018","unstructured":"Manzoor A, Moin M. Comparison of anti-inflammatory effect between intracameral triamcinolone acetonide and topical dexamethasone after phacoemulsification. Pak J Ophthalmol. 2018;34:19\u201324.","journal-title":"Pak J Ophthalmol"},{"key":"4604_CR26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7592","volume":"12","author":"KH Shaheen","year":"2020","unstructured":"Shaheen KH, Ullah MS, Hussain SA, Furqan A. Intracameral triamcinolone acetonide versus topical dexamethasone: a comparison of anti-inflammatory effects after phacoemulsification. Cureus. 2020;12:e7592. https:\/\/doi.org\/10.7759\/cureus.7592.","journal-title":"Cureus"},{"key":"4604_CR27","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/S0161-6420(99)90262-2","volume":"106","author":"DF Chang","year":"1999","unstructured":"Chang DF, Garcia IH, Hunkeler JD, Minas T. Phase II results of an intraocular steroid delivery system for cataract surgery. Ophthalmology. 1999;106:1172\u20137. https:\/\/doi.org\/10.1016\/S0161-6420(99)90262-2.","journal-title":"Ophthalmology"},{"key":"4604_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0161-6420(99)90060-X","volume":"106","author":"DT Tan","year":"1999","unstructured":"Tan DT, Chee SP, Lim L, Lim AS. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation. Ophthalmology. 1999;106:223\u201331. https:\/\/doi.org\/10.1016\/S0161-6420(99)90060-X.","journal-title":"Ophthalmology"},{"key":"4604_CR29","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/s0161-6420(01)00839-9","volume":"108","author":"DT Tan","year":"2001","unstructured":"Tan DT, Chee SP, Lim L, Theng J, Van Ede M. Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye. Ophthalmology. 2001;108:2172\u201381. https:\/\/doi.org\/10.1016\/s0161-6420(01)00839-9.","journal-title":"Ophthalmology"},{"key":"4604_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jcrs.2003.08.028","volume":"30","author":"AC Wadood","year":"2004","unstructured":"Wadood AC, Armbrecht AM, Aspinall PA, Dhillon B. Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification. J Cataract Refractive Surg. 2004;30:761\u20138. https:\/\/doi.org\/10.1016\/j.jcrs.2003.08.028.","journal-title":"J Cataract Refractive Surg"},{"key":"4604_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ophtha.2017.12.029","volume":"125","author":"E Donnenfeld","year":"2018","unstructured":"Donnenfeld E, Holland E. Dexamethasone intracameral drug-delivery suspension for inflammation associated with cataract surgery: a randomized, placebo-controlled, phase III trial. Ophthalmology. 2018;125:799\u2013806. https:\/\/doi.org\/10.1016\/j.ophtha.2017.12.029.","journal-title":"Ophthalmology"},{"key":"4604_CR32","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jcrs.2018.07.015","volume":"44","author":"ED Donnenfeld","year":"2018","unstructured":"Donnenfeld ED, Solomon KD, Matossian C. Safety of IBI-10090 for inflammation associated with cataract surgery: Phase 3 multicenter study. J Cataract Refract Surg. 2018;44:1236\u201346. https:\/\/doi.org\/10.1016\/j.jcrs.2018.07.015.","journal-title":"J Cataract Refract Surg"},{"key":"4604_CR33","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2147\/OPTH.S112080","volume":"10","author":"BL Fisher","year":"2016","unstructured":"Fisher BL, Potvin R. Transzonular vitreous injection vs a single drop compounded topical pharmaceutical regimen after cataract surgery. Clin Ophthalmol. 2016;10:1297\u2013303. https:\/\/doi.org\/10.2147\/OPTH.S112080.","journal-title":"Clin Ophthalmol"},{"key":"4604_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/ICU.0000000000000329","volume":"28","author":"SL Tyson","year":"2017","unstructured":"Tyson SL, Bailey R, Roman JS, Zhan T, Hark LA, Haller JA. Clinical outcomes after injection of a compounded pharmaceutical for prophylaxis after cataract surgery: a large-scale review. Curr Opin Ophthalmol. 2017;28:73\u201380. https:\/\/doi.org\/10.1097\/ICU.0000000000000329.","journal-title":"Curr Opin Ophthalmol"},{"key":"4604_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1089\/jop.2019.0097","volume":"35","author":"R Singhal","year":"2019","unstructured":"Singhal R, Luo A, O\u2019Rourke T, Scott IU, Pantanelli SM. Transzonular triamcinolone-moxifloxacin versus topical drops for the prophylaxis of postoperative inflammation after cataract surgery. J Ocul Pharm Ther. 2019;35:565\u201370. https:\/\/doi.org\/10.1089\/jop.2019.0097.","journal-title":"J Ocul Pharm Ther"},{"key":"4604_CR36","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.4103\/ijo.IJO_1186_19","volume":"68","author":"N Bardoloi","year":"2020","unstructured":"Bardoloi N, Sarkar S, Pilania A, Das H. Efficacy and safety of dropless cataract surgery. Indian J Ophthalmol. 2020;68:1081\u20135. https:\/\/doi.org\/10.4103\/ijo.IJO_1186_19.","journal-title":"Indian J Ophthalmol"},{"key":"4604_CR37","doi-asserted-by":"publisher","first-page":"845","DOI":"10.18240\/ijo.2024.05.08","volume":"17","author":"B Rabiee","year":"2024","unstructured":"Rabiee B, Festok M, Gaspari M, Haseeb A, Chaudhry A, Kamoun L, et al. Combinative approach of transzonular triamcinolone-moxifloxacin and perioperative drops to minimize postoperative complications of cataract surgery. Int J Ophthalmol. 2024;17:845\u201351. https:\/\/doi.org\/10.18240\/ijo.2024.05.08.","journal-title":"Int J Ophthalmol"},{"key":"4604_CR38","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.4103\/IJO.IJO_2697_23","volume":"72","author":"MS Gounder","year":"2024","unstructured":"Gounder MS, Rizvi SWA, Asharaf H, Khan AA, Ashraf S, Akhtar A. Transzonular moxifloxacin and dexamethasone delivery in phacoemulsification: a novel dropless regimen. Indian J Ophthalmol. 2024;72:1147\u20139. https:\/\/doi.org\/10.4103\/IJO.IJO_2697_23.","journal-title":"Indian J Ophthalmol"},{"key":"4604_CR39","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.4103\/ijo.IJO_830_18","volume":"66","author":"SK Pandey","year":"2018","unstructured":"Pandey SK, Sharma V. Transzonular drug delivery during cataract surgery: Is dropless cataract surgery really beneficial?. Indian J Ophthalmol. 2018;66:1377\u20139. https:\/\/doi.org\/10.4103\/ijo.IJO_830_18.","journal-title":"Indian J Ophthalmol"},{"key":"4604_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ophtha.2016.11.042","volume":"124","author":"AJ Witkin","year":"2017","unstructured":"Witkin AJ, Chang DF, Jumper JM, Charles S, Eliott D, Hoffman RS, et al. Vancomycin-associated hemorrhagic occlusive retinal vasculitis: clinical characteristics of 36 eyes. Ophthalmology. 2017;124:583\u201395. https:\/\/doi.org\/10.1016\/j.ophtha.2016.11.042.","journal-title":"Ophthalmology"},{"key":"4604_CR41","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1016\/j.ophtha.2021.10.006","volume":"129","author":"KM Miller","year":"2022","unstructured":"Miller KM, Oetting TA, Tweeten JP, Carter K, Lee BS, Lin S, et al. Cataract in the adult eye preferred practice pattern\u00ae. Ophthalmology. 2022;129:P1\u2013126. https:\/\/doi.org\/10.1016\/j.ophtha.2021.10.006.","journal-title":"Ophthalmology"},{"key":"4604_CR42","doi-asserted-by":"publisher","unstructured":"Walters T, Bafna S, Voltz S, Wortz G, Harton P, Levenson J, et al. Efficacy and safety of sustained release dexamethasone for the treatment of ocular pain and inflammation after cataract surgery: results from two phase 3 studies. J Clin Exp Ophthalmol. 2016;07. https:\/\/doi.org\/10.4172\/2155-9570.1000572","DOI":"10.4172\/2155-9570.1000572"},{"key":"4604_CR43","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jcrs.2018.09.023","volume":"45","author":"SL Tyson","year":"2019","unstructured":"Tyson SL, Bafna S, Gira JP, Goldberg DF, Jones JJ, Jones MP, et al. Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery. J Cataract Refractive Surg. 2019;45:204\u201312. https:\/\/doi.org\/10.1016\/j.jcrs.2018.09.023.","journal-title":"J Cataract Refractive Surg"},{"key":"4604_CR44","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/ph13120448","volume":"13","author":"I Mylona","year":"2020","unstructured":"Mylona I, Tsinopoulos I. A critical appraisal of new developments in intraocular lens modifications and drug delivery systems for the prevention of cataract surgery complications. Pharm (Basel). 2020;13:448 https:\/\/doi.org\/10.3390\/ph13120448.","journal-title":"Pharm (Basel)"},{"key":"4604_CR45","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jcrs.2013.08.062","volume":"40","author":"I Lipnitzki","year":"2014","unstructured":"Lipnitzki I, Ben Eliahu S, Marcovitz AL, Ezov N, Kleinmann G. Intraocular concentration of moxifloxacin after intracameral injection combined with presoaked intraocular lenses. J Cataract Refract Surg. 2014;40:639\u201343. https:\/\/doi.org\/10.1016\/j.jcrs.2013.08.062.","journal-title":"J Cataract Refract Surg"},{"key":"4604_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/pharmaceutics13070976","volume":"13","author":"N Toffoletto","year":"2021","unstructured":"Toffoletto N, Salema-Oom M, Anguiano Igea S, Alvarez-Lorenzo C, Saramago B, Serro AP. Drug-loaded hydrogels for intraocular lenses with prophylactic action against pseudophakic cystoid macular edema. Pharmaceutics. 2021;13:7 https:\/\/doi.org\/10.3390\/pharmaceutics13070976.","journal-title":"Pharmaceutics"},{"key":"4604_CR47","unstructured":"Larkin H ESCRS:Drug-Eluting IOL Haptic Ring May Enable Dropless Cataract Surgery [Internet]. [cited 2025 Apr 5]. Available from: https:\/\/www.escrs.org\/"},{"key":"4604_CR48","unstructured":"Siney EJ, Gould JM, Pitt D, Alexander P Intraocular lens comprising drug-containing microspheres [Internet]. US20190053892A1, 2019 [cited 2025 Apr 5]. Available from: https:\/\/patents.google.com\/patent\/US20190053892A1\/en"},{"key":"4604_CR49","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.2147\/OPTH.S422502","volume":"17","author":"ED Donnenfeld","year":"2023","unstructured":"Donnenfeld ED, Hovanesian JA, Malik AG, Wong A. A randomized, prospective, observer-masked study comparing dropless treatment regimen using intracanalicular dexamethasone insert, intracameral ketorolac, and intracameral moxifloxacin versus conventional topical therapy to control postoperative pain and inflammation in cataract surgery. Clin Ophthalmol. 2023;17:2349\u201356. https:\/\/doi.org\/10.2147\/OPTH.S422502.","journal-title":"Clin Ophthalmol"},{"key":"4604_CR50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/j.jcrs.0000000000000414","volume":"47","author":"ED Donnenfeld","year":"2021","unstructured":"Donnenfeld ED, Holland EJ, Solomon KD. Safety and efficacy of nepafenac punctal plug delivery system in controlling postoperative ocular pain and inflammation after cataract surgery. J Cataract Refractive Surg. 2021;47:158 https:\/\/doi.org\/10.1097\/j.jcrs.0000000000000414.","journal-title":"J Cataract Refractive Surg"},{"key":"4604_CR51","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1001\/jamaophthalmol.2015.2810","volume":"133","author":"I Mahmud","year":"2015","unstructured":"Mahmud I, Kelley T, Stowell C, Haripriya A, Boman A, Kossler I, et al. A proposed minimum standard set of outcome measures for cataract surgery. JAMA Ophthalmol. 2015;133:1247\u201352. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.2810.","journal-title":"JAMA Ophthalmol"},{"key":"4604_CR52","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41433-021-01486-1","volume":"36","author":"J Halim","year":"2022","unstructured":"Halim J, Westcott F, Cascone N, Coombes A. Risk factors associated with post-operative uveitis after cataract surgery: a retrospective case-control study. Eye (Lond). 2022;36:198\u2013205. https:\/\/doi.org\/10.1038\/s41433-021-01486-1.","journal-title":"Eye (Lond)"},{"key":"4604_CR53","unstructured":"Kaufman PL, Alm A Adler\u2019s Physiology of the Eye [Internet]. Mosby Inc.; 2003 [cited 2025 Apr 5]. Available from: https:\/\/urn.kb.se\/resolve?urn=urn:nbn:se:uu:diva-63758"},{"key":"4604_CR54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10792-010-9362-3","volume":"30","author":"MM Hermann","year":"2010","unstructured":"Hermann MM, Ust\u00fcndag C, Diestelhorst M. Electronic compliance monitoring of topical treatment after ophthalmic surgery. Int Ophthalmol. 2010;30:385\u201390. https:\/\/doi.org\/10.1007\/s10792-010-9362-3.","journal-title":"Int Ophthalmol"},{"key":"4604_CR55","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.ophtha.2014.04.035","volume":"121","author":"L Kessel","year":"2014","unstructured":"Kessel L, Tendal B, J\u00f8rgensen KJ, Erngaard D, Flesner P, Andresen JL, et al. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology. 2014;121:1915\u201324. https:\/\/doi.org\/10.1016\/j.ophtha.2014.04.035.","journal-title":"Ophthalmology"},{"key":"4604_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/encyclopedia3030065","volume":"3","author":"A Biran","year":"2023","unstructured":"Biran A, Goldberg M, Shemesh N, Achiron A. Improving compliance with medical treatment using eye drop aids. Encyclopedia. 2023;3:3 https:\/\/doi.org\/10.3390\/encyclopedia3030065.","journal-title":"Encyclopedia"},{"key":"4604_CR57","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/jpm12040514","volume":"12","author":"AC Zaharia","year":"2022","unstructured":"Zaharia AC, Dumitrescu OM, Radu M, Rogoz RE. Adherence to therapy in glaucoma treatment\u2014a review. J Pers Med. 2022;12:514 https:\/\/doi.org\/10.3390\/jpm12040514.","journal-title":"J Pers Med"},{"key":"4604_CR58","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/jcm11020367","volume":"11","author":"M Uchino","year":"2022","unstructured":"Uchino M, Yokoi N, Shimazaki J, Hori Y, Tsubota K. Adherence to eye drops usage in dry eye patients and reasons for non-compliance: a web-based survey. J Clin Med. 2022;11:367 https:\/\/doi.org\/10.3390\/jcm11020367.","journal-title":"J Clin Med"},{"key":"4604_CR59","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jcrs.2014.02.037","volume":"40","author":"JA An","year":"2014","unstructured":"An JA, Kasner O, Samek DA, Levesque V. Evaluation of eyedrop administration by inexperienced patients after cataract surgery. J Cataract Refract Surg. 2014;40:1857\u201361. https:\/\/doi.org\/10.1016\/j.jcrs.2014.02.037.","journal-title":"J Cataract Refract Surg"},{"key":"4604_CR60","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/ICU.0000000000000625","volume":"31","author":"NH Shorstein","year":"2020","unstructured":"Shorstein NH, Myers WG. Drop-free approaches for cataract surgery. Curr Opin Ophthalmol. 2020;31:67\u201373. https:\/\/doi.org\/10.1097\/ICU.0000000000000625.","journal-title":"Curr Opin Ophthalmol"},{"key":"4604_CR61","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2147\/OPTH.S448973","volume":"18","author":"L Nijm","year":"2024","unstructured":"Nijm L, Matossian C, Rhee MK, Stephens JD, Rosselson ME, Majmudar PA, et al. Early real-world patient and staff experience with an intracanalicular dexamethasone insert. Clin Ophthalmol. 2024;18:1391\u2013401. https:\/\/doi.org\/10.2147\/OPTH.S448973.","journal-title":"Clin Ophthalmol"},{"key":"4604_CR62","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2147\/PPA.S126283","volume":"11","author":"JP Gira","year":"2017","unstructured":"Gira JP, Sampson R, Silverstein SM, Walters TR, Metzinger JL, Talamo JH. Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (DextenzaTM): results of a qualitative survey. Patient Prefer Adherence. 2017;11:487\u201394. https:\/\/doi.org\/10.2147\/PPA.S126283.","journal-title":"Patient Prefer Adherence"},{"key":"4604_CR63","doi-asserted-by":"publisher","first-page":"e030110","DOI":"10.1136\/bmjopen-2019-030110","volume":"10","author":"J Thorn","year":"2020","unstructured":"Thorn J, Man MS, Chaplin K, Bower P, Brookes S, Gaunt D, et al. Cost-effectiveness of a patient-centred approach to managing multimorbidity in primary care: a pragmatic cluster randomised controlled trial. BMJ Open. 2020;10:e030110 https:\/\/doi.org\/10.1136\/bmjopen-2019-030110.","journal-title":"BMJ Open"},{"key":"4604_CR64","unstructured":"NHS Business Services Authority. NHS Business Services Authority (NHSBSA) Tariff Book. 2022."},{"key":"4604_CR65","unstructured":"National Ophthalmology Database Audit. Year 7 Annual Report \u2013 The Sixth Prospective Report of the National Ophthalmology Database Audit National Cataract Audit. 2023. Report No."},{"key":"4604_CR66","unstructured":"Chang A. Analysis of the Economic Impacts of Dropless Cataract Therapy on Medicare, Medicaid, State Governments, and Patient Costs. 2015. Report No"},{"key":"4604_CR67","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1097\/j.jcrs.0000000000001526","volume":"50","author":"S Massa","year":"2024","unstructured":"Massa S, Smits DJ, Nguyen AT, Patil SA, Chen EM, Shorstein NH, et al. Cost analysis of dropless cataract surgery prophylaxis with intracameral antibiotics and subconjunctival steroids. J Cataract Refract Surg. 2024;50:1215\u201323. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000001526.","journal-title":"J Cataract Refract Surg"},{"key":"4604_CR68","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/j.jcrs.0000000000000267","volume":"46","author":"DF Chang","year":"2020","unstructured":"Chang DF, Thiel CL, Ophthalmic Instrument C, Sterilization Task F. Survey of cataract surgeons\u2019 and nurses\u2019 attitudes toward operating room waste. J Cataract Refract Surg. 2020;46:933\u201340. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000000267.","journal-title":"J Cataract Refract Surg"},{"key":"4604_CR69","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/j.jcrs.0000000000001175","volume":"49","author":"DF Chang","year":"2023","unstructured":"Chang DF. Tackling the challenge of needless surgical waste in ophthalmology. J Cataract Refract Surg. 2023;49:333\u20138. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000001175.","journal-title":"J Cataract Refract Surg"},{"key":"4604_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000549175","volume":"249","author":"D Yang-Seeger","year":"2026","unstructured":"Yang-Seeger D, Schellstede A, Pauleikhoff LJB, Spitzer MS, Birtel J. Patients\u2019 perspectives on climate change, health, and sustainability in ophthalmology. Ophthalmologica. 2026;249:1\u20137. https:\/\/doi.org\/10.1159\/000549175.","journal-title":"Ophthalmologica"},{"key":"4604_CR71","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1016\/S2542-5196(22)00074-2","volume":"6","author":"JC Buchan","year":"2022","unstructured":"Buchan JC, Thiel CL, Steyn A, Somner J, Venkatesh R, Burton MJ, et al. Addressing the environmental sustainability of eye health-care delivery: a scoping review. Lancet Planet Health. 2022;6:e524\u2013e534. https:\/\/doi.org\/10.1016\/S2542-5196(22)00074-2.","journal-title":"Lancet Planet Health"},{"key":"4604_CR72","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1038\/s41433-024-03185-z","volume":"38","author":"AY Ong","year":"2024","unstructured":"Ong AY, Birtel J, Charbel Issa P. Greener intravitreal injections: a narrative review. Eye. 2024;38:2874\u20139. https:\/\/doi.org\/10.1038\/s41433-024-03185-z.","journal-title":"Eye"},{"key":"4604_CR73","doi-asserted-by":"publisher","unstructured":"Birtel J, Hammer M, Feltgen N, Pauleikhoff L, Ong AY, Geerling G, et al. Intravitreal injections: improving sustainability by reducing clinical waste. Klin Monbl Augenheilkd. 2024. https:\/\/doi.org\/10.1055\/a-2184-9492","DOI":"10.1055\/a-2184-9492"},{"key":"4604_CR74","doi-asserted-by":"publisher","unstructured":"Ong AY, Buckley TMW, Birtel J, de Silva SR, Stone N, Charbel Issa P. Towards greener intravitreal injections: the Oxford Eye Hospital experience. Eye. 2025;1\u20133. https:\/\/doi.org\/10.1038\/s41433-025-03899-8","DOI":"10.1038\/s41433-025-03899-8"},{"key":"4604_CR75","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00347-022-01608-4","volume":"119","author":"J Birtel","year":"2022","unstructured":"Birtel J, Heimann H, Hoerauf H, Helbig H, Schulz C, Holz FG, et al. [Sustainability in ophthalmology: adaptation to the climate crisis and mitigation]. Ophthalmologie. 2022;119:567\u201376. https:\/\/doi.org\/10.1007\/s00347-022-01608-4.","journal-title":"Ophthalmologie"},{"key":"4604_CR76","unstructured":"UKISCRS. UKISCRS [Internet]. [cited 2026 Mar 16]. Recommendations of Practice for Dropless Cataract Surgery 2026 https:\/\/www.ukiscrs.org.uk\/resources Available from"},{"key":"4604_CR77","unstructured":"Corcoran K Ophthalmology Management [Internet]. [cited 2025 Apr 6]. Payment considerations for dropless cataract surgery. Available from: https:\/\/ophthalmologymanagement.com\/issues\/2014\/december\/payment-considerations-for-dropless-cataract-surgery\/"},{"key":"4604_CR78","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/ACM.0000000000003122","volume":"95","author":"E Teisberg","year":"2020","unstructured":"Teisberg E, Wallace S, O\u2019Hara S. Defining and implementing value-based health care: a strategic framework. Acad Med. 2020;95:682\u20135. https:\/\/doi.org\/10.1097\/ACM.0000000000003122.","journal-title":"Acad Med"},{"key":"4604_CR79","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMp1011024","volume":"363","author":"ME Porter","year":"2010","unstructured":"Porter ME. What is value in health care?. N Engl J Med. 2010;363:2477\u201381. https:\/\/doi.org\/10.1056\/NEJMp1011024.","journal-title":"N Engl J Med"},{"key":"4604_CR80","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/eye.2000.11","volume":"14","author":"JH Tan","year":"2000","unstructured":"Tan JH, Newman DK, Klunker C, Watts SE, Burton RL. Phacoemulsification cataract surgery: is routine review necessary on the first post-operative day?. Eye (Lond). 2000;14:53\u201355. https:\/\/doi.org\/10.1038\/eye.2000.11.","journal-title":"Eye (Lond)"},{"key":"4604_CR81","first-page":"16","volume":"8","author":"Y Nochez","year":"2014","unstructured":"Nochez Y. Chirurgie de la cataracte. Prise en Charg postop\u00e9ratoire. 2014;8:16\u201321. Vol. 8.","journal-title":"Prise en Charg postop\u00e9ratoire"},{"key":"4604_CR82","first-page":"1757","volume":"18","author":"SA Rattan","year":"2018","unstructured":"Rattan SA, Mohammad NK, Mutashar MK. Two different chemoprophylaxis approaches after phacoemulsification surgery in one thousand patients in Iraq. Int Eye Sci. 2018;18:1757\u201362.","journal-title":"Int Eye Sci"},{"key":"4604_CR83","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1038\/s41433-024-03055-8","volume":"38","author":"J Birtel","year":"2024","unstructured":"Birtel J, Mole G, Aslam SA, Charbel Issa P. Dropless After Cataract Surgery (DACS) for patients with difficulties using eye drops. Eye. 2024;38:1972\u20133. https:\/\/doi.org\/10.1038\/s41433-024-03055-8.","journal-title":"Eye"},{"key":"4604_CR84","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.2147\/OPTH.S247739","volume":"14","author":"Z Haq","year":"2020","unstructured":"Haq Z, Zhang MH, Benjamin MJ, Riaz KM. Short-term non-infectious outcomes after a pars plana intravitreal antibiotic-steroid injection of triamcinolone, moxifloxacin, and vancomycin during cataract surgery versus a standard postoperative topical regimen. Clin Ophthalmol. 2020;14:1117\u201325. https:\/\/doi.org\/10.2147\/OPTH.S247739.","journal-title":"Clin Ophthalmol"},{"key":"4604_CR85","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.jcrs.2015.11.005","volume":"41","author":"T Walters","year":"2015","unstructured":"Walters T, Endl M, Elmer TR, Levenson J, Majmudar P, Masket S. Sustained-release dexamethasone for the treatment of ocular inflammation and pain after cataract surgery. J Cataract Refract Surg. 2015;41:2049\u201359. https:\/\/doi.org\/10.1016\/j.jcrs.2015.11.005.","journal-title":"J Cataract Refract Surg"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04604-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04604-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04604-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:09:14Z","timestamp":1785517754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04604-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":85,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4604"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04604-z","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}